Bristol-Myers Squibb 00003363112 Reyataz Atazanavir Sulfate 200 mg Capsule Bottle 60 Capsules

REYATAZ (atazanavir sulfate) is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection

Manufacturer # 00003363112
Brand Reyataz®
Manufacturer Bristol-Myers Squibb
Country of Origin Unknown
Application Protease Inhibitor
Container Type Bottle
Dosage Form Capsule
Generic Drug Code 19953
Generic Drug Name Atazanavir Sulfate
Is_Active_Vendor Y
Is_DSCSA N
Is_Discontinued N
Is_Medical_Device Y
Lot_Tracking_Flag N
NDC Number 00003363112
On_Allocation N
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Quantity 60 Capsules
Strength 200 mg
Supplier_ID 3885243
UNSPSC Code 51342713